The investigating judge is expected to hear the case today (6/14) the 51-year-old pharmacist for operating an illegal laboratory for the production and distribution of pharmaceutical preparations and doping substances in Chalandri.
According to the investigation, the network in question is alleged to have operated internationally, with more than 15,000 orders in approximately 90 countries. Authorities estimate that the total value of the seized products exceeds 600,000 euros, while the total turnover is reported to exceed 1 million euros.
Chalandri: The pharmacy’s basement and the ring’s operations
The illegal laboratory is believed to have been operating for at least the past six months. According to the investigation, the premises were used to manufacture weight-loss products, erectile dysfunction treatments, anabolic substances, and stimulants.
Prior to the main defendant’s plea, four other individuals allegedly linked to the case had already appeared before the judicial authorities.
Reports indicate that a total of ten people had access to the basement, including biologists and pharmacists, who participated in the manufacture and distribution of the products.
The 51-year-old is also alleged to have advertised the products via social media, presenting himself as a certified manufacturer of “handmade preparations.” At the same time, he participated as a speaker at international forums.
The complaints and the company’s role
According to the president of EOF, Spyros Sapounas, there had been repeated complaints from Greece and abroad regarding shipments of illegal preparations.
The role of a company based in Halandri, owned by a British citizen who is wanted by the authorities, is also considered crucial. The investigation is focusing on the company’s possible connections to the supply of raw materials and the management of shipments.
Evidence so far suggests that the raw materials were of dubious origin, while prescriptions were reportedly issued through “ghost doctors.”
Those involved are also said to have used code names for the products in order to evade inspections and conceal the true nature of the transactions.
Concerns about the substances detected
Authorities are particularly concerned that substances still in the research stage and not approved for widespread use were detected in some of the formulations.
Investigators are examining the possibility of serious risks to public health, as several of the products appear to have been distributed without any safety checks.
On the defense side, a lawyer for one of the pharmacy employees argued that “there are no specific characteristics that would render their actions criminal,” challenging the manner in which the charges are being brought against those involved.
